Helicos BioSciences, a Cambridge, MA-based DNA firm developing DNA analysis technology, announced today that is has closed a $20 million credit facility with GE Healthcare Financial Services. Helicos, which received the first half of the money available under the loan agreement on December 31 and can draw down the remainder by June 30, says in a statement that the funds will “provide flexibility as we scale up our manufacturing and build inventory to meet customer demand in 2008 and beyond.”
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
